Rein Therapeutics Inc. announced that its Board of Directors approved an amendment to the company's Amended and Restated By-laws. The amendment, effective immediately, specifies that a quorum at all stockholder meetings will require forty percent of the shares of capital stock issued and outstanding and entitled to vote, whether present in person, by remote communication, or represented by proxy.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rein Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-158192), on July 11, 2025, and is solely responsible for the information contained therein.